Brazil seeks two million doses of Covishield vaccine from India on priority basis

▴ Brazil seeks two million doses of Covishield vaccine from India on priority basis
Brazilian President Jair Bolsonaro has requested India for 2 million doses of Covishield vaccine produced indigenously by the Serum Institute of India, Pune.

Brazilian President Jair Bolsonaro has requested India for 2 million doses of Covishield vaccine produced indigenously by the Serum Institute of India, Pune.

Mr. Bolsonaro has written a letter to Prime Minister Narendra Modi to expedite the shipment of the Covishield vaccine to Brazil without affecting India's vaccination program.

Mr. Bolsonaro's letter, released by his press office, comes amid growing pressure to speed up Brazil's vaccine rollout and end the world's second-deadliest coronavirus outbreak. Brazilian National Immunization Program has finalized the Covishield and Covaxin for emergency use in the country.

Earlier, the federally funded Fiocruz biomedical center had requested an emergency use authorization for the Covishield vaccine coming from India.

Tags : #BrazilCovidUpdates #India #RequestfortwomilliondosesofCovishieldVaccine #CovishieldVaccine #IndianCovid-19Vaccine #SerumInstituteofIndia #PrimeMinister #NarendraModi #Indiasvaccinationprogram #Covaxin #FightAgainstCovid

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024